Finally, within the DN CD56+ T cell subset, we found an increase in the percentage of DNAM-1+TIGIT+TACTILE+ cells (p <0.05) in AML patients compared with healthy donors (Figure 5b, lower row, and Figure 7c). This evidence concerns the gene CD226 and acute myeloid leukemia.